A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Phase
3Span
501 weeksSponsor
Regeneron PharmaceuticalsViagrande
Recruiting
1-1 of 1